Source: SEC.GOV

ICS: Innovative Cardiovascular Solutions raised $654.6K in a Debt round

Innovative Cardiovascular Solutions raised $654.6K in a Debt round

Read full article »

ICS's Competitors | ICS's News | ICS's Financials

Followers on Owler

Est. Annual Revenue

$5.0-25M

Est. Employees

25-100

Co-Founder & CEO

R. Kevin Plemmons

CEO Approval Rating

88/100

ICS is a Michigan-based medical device company that designs and provides embolic protection devices for the treatment of TAVR and other left-sided heart procedures.